Evidence to date suggests that the liquid form of iron supplementation has comparable efficacy to the tablet formulation, but with significantly lower gastrointestinal side effects. The evidence...
John (a pseudonym used to protect his identity) was a 54 year-old man who was referred to the mental health crisis resolution team by his GP after attempting suicide. There had been a 1-month history...
On the 21 February 2023, it was announced that the UK government would start subsidising the price of hormone replacement therapy (HRT), with around 400 000 women in England potentially benefiting...
The UK government has announced a new initiative to make hormone replacement therapy (HRT) more affordable for women experiencing symptoms of menopause. The move is expected to benefit hundreds of...
With the help of Prescribing and Therapeutics Training Ltd and the Journal of Prescribing Practice, you can earn your 1-hour CPD certificate .
Diabetes UK (2023), together with the American Diabetes Association and the European Association for the Study of Diabetes, defines remission as HbA1c levels remaining below 48 mmol/mol or 6.5% for...
In November 2022, van Dyck et al (2022) reported the results of an 18-month, double-blind, phase 3 trial of 1795 participants with early Alzheimer’s disease and evidence of amyloid. Half received...
A visit to my GP recently, which required a prescription, led me to ask myself: when was the last time I held a paper FP10 green prescription in my hand? As someone with a long-term condition...
NICE has recommended a weekly injection for treating growth failure in children. The recommended treatment, known as growth hormone therapy, involves a weekly injection of a hormone called somatropin....
Day 1: In the 1990s, growing insight into incretin roles in type 2 (T2DM) diabetes led to an interest in the breakdown of gut hormone GLP-1. DPP-4 was identified as the best peptidase target and a...
A new study published in the British Medical Journal has examined whether the use of the receptor agonist glucagon-like peptide 1 (GLP-1), dipeptidyl peptidase 4 (DPP-4) inhibitors, and sodium-glucose...
This piece of original research published in July 2022 aimed to elucidate the burden and associated cost of ADRs, polypharmacy and multimorbidity with a prospective analysis of all medical admissions...
Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.
Evidence-based best practice
Drug updates
Pharmacology information
Calculation skills